Elgamal, Shimaa
Ahmed, Sherihan Rezk
Nahas, Mohamed M.
Hendawy, Shimaa R.
Elshafei, Osama
Zeinhom, Mohamed G. http://orcid.org/0000-0002-0337-349X
Clinical trials referenced in this document:
Documents that mention this clinical trial
The effect of lacosamide on calcitonin gene-related peptide serum level in episodic migraine patients: a randomized, controlled trial
https://doi.org/10.1007/s13760-024-02499-9
Funding for this research was provided by:
Kafr El Shiekh University
Article History
Received: 15 August 2023
Accepted: 8 February 2024
First Online: 19 March 2024
Declarations
:
: All authors declare no conflict of interests.
: Our study had the approval of the ethical committee of Kafr-el Sheikh University, and the ethical reference number is (MKSU 50-11-15). All methods of our trial were performed following the guidelines and regulations of the Faculty of Medicine Ain Shams University (FMASU), which is organized and operated according to the guidelines of the International Council on Harmonization ICH), Anesthesiology and the Islamic Organization for Medical Service (IOMS), the United States Office for Human Research Protections, and the United States Code of Federal Regulations, and operates under Federal Wide Assurance no (FWA00001785). Our trial is registered in clinicaltrials.gov under NCT05632133.
: Before randomization, formal written informed consent was obtained from the included patients or their first-degree relatives.